Vaxart
Clinical trials sponsored by Vaxart, explained in plain language.
Vaxart
VXRT
NASDAQ
A clinical-stage biotech developing oral vaccines using a proprietary delivery platform.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a pill replace the COVID-19 booster shot? Results expected May 2027 (estimated)